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84 from Arita et al., used the following degrees for each eyelid: 0 (no loss of meibomian glands); 1 (loss 85 of the meibomian gland involving less than one-third of the total meibomian gland area); 2 (loss 86 between one third and two thirds of the total area of the meibomian gland); and 3 (loss more than 87 two-thirds of the total meibomian gland area). [11] 88 4. Assessment of pterygium: pterygium pictures were used to classification in degrees: grade 1 to 89 4 according to fibrovascular tissue extension towards the cornea (grade 1 when the lesion reaches the 90 limbus, grade 2 when it covers the cornea at about 2 mm, grade 3 when it reaches the pupil margin 91 and grade 4 when it exceeds the pupil). Indeed, biomicroscopic aspect was noted as involutive Red eye (0-10) 9  1 7.7 -10 7.7  2.8 6.6 -8.8 0.82 Irritation (0-10) 7  2 4.5 -9.4 6.8  2.5 5.9 -7.8 0.51 Tearing (0-10) 6.4  2.6 3 -9.6 5.8  3. 
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We found that 88% of patients presented abnormalities on meibomian glands. Interestingly, in 126 54% of the upper eyelids and 77% of the lower eyelids, the meibomian gland loss appeared nasally 127 in the same localization of the pterygium. 161 Schirmer I test in eyes with pterygium when compared to healthy eyes, which can be explained by 162 the significantly higher tear osmolarity levels found in the study.
[6] In our study pterygium patients 163 had statistically higher tear meniscus height and no differences in NITBUT, which may be pointed 164 as a picture of the ocular surface compensatory mechanisms. Higher measurements of tear meniscus 165 may be related to chronic ocular inflammation and friction and abnormal distribution of tear film 166 leading to surface disturbances in tear flow dynamics and reflex tearing, as described in previous 167 studies. [16] Although, normal tear function and no alteration on tear meniscus height has been 168 already described in the pterygium patients [14, 17] 175 Meibomian gland dysfunction was found in a significant number of pterygium patients.
176 Interestingly, areas of meibomian gland loss coincidently correlated to the nasal topography 177 localization of the pterygium, both in the upper and lower eyelids. Another study reported 178 morphological changes in such pterygium-associated glands when compared to healthy eyes, 179 demonstrating that patients with pterygium had a significantly higher degree of meibomian gland loss 180 when compared to normal patients, but to our knowledge, no association with pterygium localization 181 was described before. 
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The present study shows that pterygium impacts on ocular surface parameters, especially by 207 inducing direct alterations in the pattern of meibomian glands and tear film.
